Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

R. Kanesvaran · SciRah

Researcher profile · Semantic Scholar

R. Kanesvaran

Share profile

R. Kanesvaran — researcher profile on SciRah

h-index: 43
Works: 455
Citations: 7,901

Most-cited papers

Adequate assessment yields appropriate care—the role of geriatric assessment and management in older adults with cancer: a position paper from the ESMO/SIOG Cancer in the Elderly Working Group
K. Loh, G. Liposits, S. Arora, N. Neuendorff +14 more
2024ESMO Open94 citations Open access
Semantic Scholar
Geriatric Assessment: ASCO Global Guideline
C. Bergerot, S. Temin, H. Verduzco-Aguirre, Matti S. Aapro +13 more
2025JCO Global Oncology38 citations Open access
Semantic Scholar
Advanced and metastatic prostate cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.
K. Fizazi, G. Attard, A. Azad, G. Baciarello +29 more
2026Annals of Oncology30 citations Open access
Semantic Scholar
First-line immune-based combinations or sunitinib in favorable-risk metastatic renal cell carcinoma: a real-world retrospective comparison from the ARON-1 study
G. Roviello, J. Molina-Cerrillo, F. Massari, L. Cerbone +22 more
2025Cancer Immunology and Immunotherapy19 citations Open access
Semantic Scholar
Papillary Renal Cell Carcinoma: Outcomes for Patients Receiving First-line Immune-based Combinations or Tyrosine Kinase Inhibitors from the ARON-1 Study.
F. Massari, V. Mollica, O. Fiala, U. de Giorgi +20 more
2024European Urology Oncology17 citations Open access
Semantic Scholar
Antibody Drug Conjugates in Urological Cancers: A Review of the Current Landscape
A. Ghose, P. Lapitan, Vedika Apte, A. Ghosh +13 more
2024Current Oncology Reports16 citations Open access
Semantic Scholar
Cabozantinib (C) in combination with nivolumab (N) and ipilimumab (I) in previously untreated advanced renal cell carcinoma (aRCC): Final results of COSMIC-313.
L. Albiges, R. Motzer, S. Trevino, R. Kanesvaran +16 more
2025Journal of Clinical Oncology12 citations
Semantic Scholar
SGNDV-001: disitamab vedotin with pembrolizumab in HER2-expressing locally advanced or metastatic urothelial carcinoma
T. Powles, E. Grande, Nimira Alimohamed, Niara Oliveira +10 more
2025Future Oncology12 citations Open access
Semantic Scholar
Clinical features and response to immune combinations in patients with renal cell carcinoma and sarcomatoid de‐differentiation (ARON‐1 study)
C. Ciccarese, T. Büttner, L. Cerbone, I. Zampiva +31 more
2024International Journal of Cancer12 citations Open access
Semantic Scholar
Individualizing first-line treatment for advanced urothelial carcinoma: A favorable dilemma for patients and physicians.
E. Grande, Syed A. Hussain, P. Barthélémy, R. Kanesvaran +4 more
2025Cancer Treatment Reviews10 citations Open access
Semantic Scholar
Pembrolizumab plus Lenvatinib in patients with metastatic Renal Cell Carcinoma: real-world evidences from the international ARON- 1 study
C. Porta, F. Massari, T. Taha, E. Grande +27 more
2025Cancer Immunology and Immunotherapy10 citations Open access
Semantic Scholar
Real-World Impact of Upfront Cytoreductive Nephrectomy in Metastatic Non-Clear Cell Renal Cell Carcinoma Treated with First-Line Immunotherapy Combinations or Tyrosine Kinase Inhibitors (A Sub-Analysis from the ARON-1 Retrospective Study)
O. Fiala, S. Buti, A. Bamias, F. Massari +26 more
2024Targeted oncology10 citations Open access
Semantic Scholar
Immune-based Combinations in Intermediate-/Poor-risk Patients with Non-clear Cell Renal Cell Carcinoma: Results from the ARON-1 Study.
F. Massari, V. Mollica, R. M. Kopp, E. Grande +35 more
2025European Urology Focus9 citations
Semantic Scholar
Selective treatment de‐escalation in advanced prostate cancer: have we come full circle?
B. Chong, M. Saad, Tsung-Wen Chong, John Thng +15 more
2025BJU International9 citations Open access
Semantic Scholar
Pembrolizumab in Patients with Advanced Urothelial Carcinoma with ECOG Performance Status 2: A Real-World Study from the ARON-2 Project
A. Rizzo, F. Monteiro, Y. Ürün, F. Massari +21 more
2024Targeted oncology8 citations
Semantic Scholar
Cabozantinib plus nivolumab and ipilimumab in previously untreated, advanced renal cell carcinoma: final results and biomarker analyses from the phase III COSMIC-313 study
R. Motzer, L. Albiges, S. A. Treviño Aguirre, R. Kanesvaran +18 more
2026Annals of Oncology7 citations Open access
Semantic Scholar
The ESMO/SIOG Cancer in the Elderly Working Group pragmatic strategies for clinical trial designs and endpoints in older adults with cancer
C. Baldini, A. R. A. Mislang, Kwok-Leung Cheung, S. Pilleron +19 more
2026ESMO Open7 citations Open access
Semantic Scholar
Quality-of-care indicators for oncology management: an analysis of Asia-Pacific healthcare and oncology indicators
R. Kanesvaran, E. Wong, B. Keam, N. Prasongsook +2 more
2025ESMO Open7 citations Open access
Semantic Scholar
Health-related quality of life in Singapore: Population norms for the EQ-5D-5L and EORTC QLQ-C30.
Jaclyn Tan, Mervyn JR Lim, R. Kanesvaran, Richard Norman +5 more
2025Annals of the Academy of Medicine, Singapore7 citations Open access
Semantic Scholar
Knowledge, Attitudes, and Health-Seeking Behavior for Cervical, Breast, and Oral Cancers Among Women in Jashore, Bangladesh: A Cross-Sectional Study.
M. Azim, E. Wong, Md Mahfujur Rahman, Md. Sirajul Islam +5 more
2025JCO Global Oncology7 citations Open access
Semantic Scholar
Real-world outcomes of pemetrexed-platinum chemotherapy plus osimertinib after progression on first-line osimertinib in advanced EGFR-mutated NSCLC.
S. Saw, Yi Fen Low, G. Lai, Landon L. Chan +16 more
2024Lung Cancer7 citations Open access
Semantic Scholar
Real-World Primary Resistance to First-Line Immune-Based Combinations in Patients with Advanced Renal Cell Carcinoma (ARON-1)
D. Santini, Hao-Ran Li, G. Roviello, Se Hoon Park +30 more
2024Targeted oncology7 citations
Semantic Scholar
Pan-Asian subgroup analysis of EV-302/KEYNOTE-A39: a phase 3 study to evaluate enfortumab vedotin and pembrolizumab in patients with untreated advanced urothelial carcinoma
E. Kikuchi, M. S. van der Heijden, B. Valderrama, Shilpa Gupta +16 more
2026International Journal of Clinical Oncology6 citations Open access
Semantic Scholar
Pembrolizumab-axitinib versus nivolumab-cabozantinib as first-line therapy in patients with metastatic renal cell carcinoma: a retrospective real-world comparison (ARON-1)
M. Santoni, G. Roviello, E. Grande, U. de Giorgi +32 more
2025Cancer Immunology and Immunotherapy6 citations Open access
Semantic Scholar
Management of advanced prostate cancer in the Asia‐Pacific region: Summary of the Asia‐Pacific Advanced Prostate Cancer Consensus Conference 2023
Edmund Chiong, D. Murphy, N. Buchan, Kenneth Chen +23 more
2024Asia-Pacific Journal of Clinical Oncology6 citations Open access
Semantic Scholar
STELLAR-304: a phase III study of zanzalintinib (XL092) plus nivolumab in advanced non-clear cell renal cell carcinoma
S. Pal, T. Powles, R. Kanesvaran, J. Molina-Cerrillo +7 more
2025Future Oncology5 citations Open access
Semantic Scholar
Prognostic [68Ga]Ga‐PSMA‐11 PET Biomarkers for [177Lu]Lu‐PSMA Radioligand Therapy in Metastatic Castrate‐Resistant Prostate Cancer (Asian Population Study)
Nicola Xin Yi Koh, Ming-Chua Wei, W. Lam, A. Tong +4 more
2025Asia-Pacific Journal of Clinical Oncology5 citations
Semantic Scholar
The evolving value assessment of cancer therapies: Results from a modified Delphi study
Myrto Lee, H. Larose, Martin Gräbeldinger, Jon Williams +19 more
2024Health Policy OPEN5 citations Open access
Semantic Scholar
Guiding first-line treatment decisions in advanced urothelial carcinoma: a global survey
E. Grande, J. Bellmunt, S. Hussain, M. Al Mansour +25 more
2025The Oncologist3 citations Open access
Semantic Scholar
EGFR mutation status affects intra-tumoural heterogeneity of PD-L1 expression but not agreement between assays in resectable non-small cell lung cancer.
S. Saw, Angela M. Takano, Siqin Zhou, N. O. Hlaing +16 more
2025Lung Cancer3 citations Open access
Semantic Scholar
Primary MRI versus PSA-gated scans in Prostate Cancer Screening – how ready is it for mainstream implementation?
Jun-Heng Lim, C. Y. Lo, R. Sultana, J. Y. J. Tay +7 more
2025Prostate Cancer and Prostatic Diseases3 citations
Semantic Scholar
The LuxAR-02 phase II study of luxdegalutamide in combination with [ 177 Lu]Lu-PSMA-617 in patients with prostate-specific membrane antigen (PSMA)–positive metastatic castration resistant prostate cancer (mCRPC).
D. Petrylak, Phillip H. Kuo, G. Gravis, M. Hacker +6 more
2026Journal of Clinical Oncology2 citations
Semantic Scholar
Safety and Efficacy of Lutetium‐177 PSMA Radioligand Therapy in Metastatic Castration‐Resistant Prostate Cancer with Diffuse Bone Metastases (Asian Population Study)
C. W. Q. Ng, Ming-Chua Wei, W. Lam, A. Tong +8 more
2025Asia-Pacific Journal of Clinical Oncology2 citations
Semantic Scholar
Efficacy of Enfortumab Vedotin After Platinum Chemotherapy and Pembrolizumab in Metastatic Urothelial Carcinoma: A Multicenter Real-World Analysis of the ARON-2EV Cohort
O. Fiala, F. Grillone, Kazutoshi Fujita, Enrique Grande +28 more
2025European Urology Open Science2 citations Open access
Semantic Scholar
High clinical actionability of a pan-cancer tissue-based combined DNA and RNA next generation sequencing assay in a diverse Asian population
J. Lee, A. El Helali, D. J. J. Tan, Zi-Yi Wan +15 more
2025npj Precision Oncology2 citations Open access
Semantic Scholar
Transcriptomic predictors of prostate cancer recurrence following focal cryotherapy: a pooled analysis of phase II trial and prospective cohort data
K. Tay, Bo-On-Hao Hong, E. Ong, K. M. Tan +22 more
2025Journal of the National Cancer Center2 citations
Semantic Scholar
Lost opportunities: the underutilization of castrate-resistant prostate cancer treatment in real-world settings
R. Gatsinga, Yu-Guang Tan, Wei-Ren Chen, Xin-Yan Yang +7 more
2024Translational Andrology and Urology2 citations Open access
Semantic Scholar
Mini-review: Evaluation and Management of Retroperitoneal Masses in Patients with Testicular Cancer.
Xin-Yan Yang, Jing-Qiu Li, J. Chin, R. Kanesvaran
2024European Urology Focus2 citations
Semantic Scholar
Efficacy of post-lenvatinib treatments in patients (pts) with advanced renal cell carcinoma (aRCC).
J. Panian, C. Zhong, Sharon H. Choi, R. Quinn +16 more
2024Journal of Clinical Oncology2 citations
Semantic Scholar
Evaluation of Intervention Strategies to Improve Follow-Up Colonoscopy After Abnormal FIT/FOBT Result: A Systematic Review and Meta-Analysis.
Yu-Chua Wei, Luke Xavier Chew, C. Chan, Zoe Tong +12 more
2026JAMA Internal Medicine1 citations Open access
Semantic Scholar
Real-world incidence of G3-G4 adverse events with enfortumab vedotin in patients with advanced urothelial carcinoma (ARON-2EV study)
P. Giannatempo, Shilpa Gupta, M. Rizzo, Karl Mayrhofer +26 more
2026Scientific Reports1 citations Open access
Semantic Scholar
Liver metastases in advanced urothelial carcinoma (ARON-2): do pembrolizumab and avelumab make a difference in a poor-prognosis scenario?
L. Cerbone, G. Roviello, Fabio Calabrò, T. Taha +27 more
2026Frontiers in Immunology1 citations Open access
Semantic Scholar
Cancer incidence and mortality among older adults in Asia: Estimates for 2022 and projections to 2050.
Richa Shah, R. Kanesvaran, V. Noronha, Sophie Pilleron
2026Cancer Epidemiology1 citations
Semantic Scholar
Outcomes of a prospective cohort study of PREoperative therapy and supportive care in early & locally advanced breast cancers—PreSCella study
Han-Yi Lee, W. Ong, J. Tan, Jun Ma +22 more
2026npj Breast Cancer1 citations Open access
Semantic Scholar
Targeted therapy for older patients with an oncogene driven non-small cell lung cancer: Recommendations from a SIOG expert group.
L. Decoster, D. Camidge, J. Fletcher, A. Addeo +5 more
2025Lung Cancer1 citations Open access
Semantic Scholar
EORTC QLU-C10D was similarly valid and sensitive as EQ-5D-5L but more responsive to cancer patients' health deterioration.
Lu-Ying Wang, Mihir Gandhi, R. Kanesvaran, Mohamad Farid bin Harunal Rashid +5 more
2025Journal of Clinical Epidemiology1 citations Open access
Semantic Scholar
Advancing breast cancer and lung cancer screening: Expert perspectives to advance programmes in Singapore.
Clive Tan, E. Tan, G. P. Tan, R. Kanesvaran
2025Annals of the Academy of Medicine, Singapore1 citations Open access
Semantic Scholar
BCG response and oncological outcomes in high risk nonmuscle invasive bladder cancer following previously treated upper tract urothelial carcinoma: A propensity-matched analysis.
B. Lim, K. Y. Fong, T. Lu, J. Ong +13 more
2025Urologic oncology1 citations Open access
Semantic Scholar
Inefficiencies in precision medicine: can genetic counsellors (GC) be the solution? The experience from the first GC-led cancer genetics service in Asia
Jeanette Yuen, Shao-Tzu Li, Eliza Courtney, Manasadevi Karthikeyan +9 more
2025Journal of Medical Genetics1 citations
Semantic Scholar
3105P Sex-associated outcomes and Nectin-4 expression in Enfortumab Vedotin-treated advanced urothelial carcinoma
T. Taha, A. Alpert, J. Baranseh, E. Grande +11 more
2025Annals of Oncology1 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

J. Molina-Cerrillo×12
Invite
J. Molina-Cerrillo — researcher profile on SciRah
S. Buti×12
Invite
S. Buti — researcher profile on SciRah
M. Santoni×11
Invite
M. Santoni — researcher profile on SciRah
F. Massari×10
Invite
F. Massari — researcher profile on SciRah

×10

Invite

E. Grande — researcher profile on SciRah

Invite

O. Fiala — researcher profile on SciRah

Renate Pichler×8

Invite

Renate Pichler — researcher profile on SciRah

Invite

G. Roviello — researcher profile on SciRah

Invite

M. Bourlon — researcher profile on SciRah

Invite

Z. Myint — researcher profile on SciRah

Invite

R. M. Kopp — researcher profile on SciRah

Andrey Soares×6

Invite

Andrey Soares — researcher profile on SciRah